Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Licenses SNP-IT Tech to Estonian Start Up

NEW YORK, Jan. 24 - Estonian genotyping company Asper Biotech will use Orchid BioSciences' SNP-IT technology in a new slide-based array product aimed at bioscience research, the companies said on Thursday.


Under the deal, which is arranged as a non-exclusive license, Orchid will receive an upfront payment and royalties on sales. The companies did not disclose details.


SNP-IT is Orchid's primer extension SNP scoring technology. Asper's system, called Genorama, is a four-color SNP scoring device for medium-throughput genotyping.


Asper Biotech is a privately held biotech firm founded in 1999 in Tartu, Estonia. Last summer it launched a p53 gene-sequencing and mutation-detection bioarray chip. It is also involved with the Estonian government and Gene Bank project in efforts to establish a population genetics database.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.